ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 37

Regulation of Osteoclast and T Cell Differentiation By DC-STAMP and TRAF3

Yahui Grace Chiu1, Jinbo Li2, Dongge Li1, Brendan Boyce2 and Christopher T. Ritchlin3, 1Allergy, Immunology and Rheumatology, University of Rochester, Rochester, NY, 2Pathology, University of Rochester, Rochester, NY, 3Allergy Immunology & Rheumatology, University of Rochester Medical Center, Rochester, NY

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: bone biology, osteoclastogenesis, osteoclasts and osteoporosis, T cells

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Biology and Pathology of Bone and Joint: Osteoclasts, Osteoblasts and Bone Remodeling

Session Type: Abstract Submissions (ACR)

Background/Purpose

DC-STAMP (Dendritic Cell-Specific Transmembrane Protein) is a 7-pass transmembrane protein essential for cell-to-cell fusion during OC differentiation. We have previously shown that DC-STAMP is a specific cell surface marker of OC precursors (OCP) and the frequency of DC-STAMP+cells is elevated in patients with psoriatic arthritis (PsA). Intriguingly, we found that the level of TNF receptor-associated factor 3 (TRAF3) was also significantly elevated in the OCPs of PsA patients. In addition, osteoporosis can be prevented in mice by reducing osteoclastogenesis through inhibition of TRAF3 degradation by chloroquine. Although both DC-STAMP and TRAF3 play critical roles in OC formation, it is unknown if there is an interplay between these two molecules during osteoclastogenesis. Herein, to investigate a possible mutual regulation between them, we quantified and monitored these two proteins in DC-STAMP knock-out (KO) mice and TRAF3 conditional KO (cKO) mice.

Methods

We analyzed the expression of DC-STAMP and TRAF3 in the spleen, thymus, lymph nodes, bone marrow and skeleton by flow cytometry and Western blotting in the TRAF3 KO and DC-STAMP KO mouse strains. We also examined the effects of chloroquine on the expression of DC-STAMP and TRAF3. The TRAF3 cKO mouse line was established by conditional deletion of TRAF3 in OC lineage cells by crossing Traf3fl/fland CatK-Cre.

Results

In DC-STAMP KO mice, TRAF3+ T cells were identified in the bone marrow, bone, spleen, lymph nodes, but not in the thymus. We showed that the DC-STAMP deficiency blocked the differentiation of TRAF3+CD8+T cells in thymus, and TRAF3 protein was not present in the thymus by Western blot analysis. In contrast, the expression level of DC-STAMP and DC-STAMP+ cell frequency was unchanged in the TRAF3 cKO mice. Chloroquine treatment increased the expression levels of extracellular DC-STAMP and intracellular TRAF3 and prevented osteoclast formation in human PBMC cell cultures.

Conclusion

The expression of DC-STAMP is normal in the TRAF3 cKO mouse cells, whereas TRAF3 expression was dramatically decreased in the thymus of DC-STAMP KO mice. Our results suggest that (1) DC-STAMP is critical for the regulation of T cell differentiation in the thymus; (2) DC-STAMP and TRAF3 are both required for osteoclastogenesis; (3) chloroquine exerts its negative osteoclastogenic effect by inhibiting the degradation of both TRAF3 and DC-STAMP. Thus, understanding the molecular events that regulate the synthesis and degradation of DC-STAMP and TRAF3 may reveal novel therapeutic targets in metabolic and inflammatory bone diseases.


Disclosure:

Y. G. Chiu,
None;

J. Li,
None;

D. Li,
None;

B. Boyce,
None;

C. T. Ritchlin,

Eli Lilly and Company,

9,

Eli Lilly and Company,

5.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/regulation-of-osteoclast-and-t-cell-differentiation-by-dc-stamp-and-traf3/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology